Jazz Pharmaceuticals plc
JAZZNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $14.88B
- P/E (TTM)
- 15.82
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $128.80$266.38
- Volume (live)
- -
- Avg. volume (3M)
- 774.42K
Jazz Pharmaceuticals (JAZZ) Stock Price & Financial Analysis
Jazz Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $212.19 - $217.57 |
|---|---|
| 52-Week High | $266.38 |
| 52-Week Low | $128.80 |
| Open | $212.19 |
| Volume (last close) | 886.41K |
| Average Volume (3M) | 774.42K |
| Revenue (TTM) | 4.60B |
|---|---|
| Net Income (TTM) | 940.76M |
| Free Cash Flow (TTM) | 1.47B |
| EPS (TTM) | $14.58 |
| Profit Margin | 20.45% |
| Operating Margin | 33.65% |
| Return on Equity (ROE) | 19.59% |
| Debt to Equity | 0.92 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 14.88B |
|---|---|
| Shares Outstanding | 69.40M |
| P/E Ratio (TTM) | 15.82 |
| Price to Sales (P/S) | 3.23 |
| Price to Book (P/B) | 3.10 |
| EV/EBITDA | 11.31 |
| 50-Day MA | $241.81 |
|---|---|
| 200-Day MA | $214.05 |
| 1-Year Change | +59.72% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Jazz Pharmaceuticals at a Glance
As of the Oct 15, 2026 close, Jazz Pharmaceuticals (JAZZ) has a market capitalization of $14.88B. The stock trades at 15.8× trailing earnings and 3.2× sales. Over the trailing twelve months it earned $940.76M on revenue of $4.60B (a 20.4% profit margin) and generated $1.47B of free cash flow. Revenue grew 12.6% year over year.
As of its latest reported balance sheet, it holds $1.62B in cash and securities against $4.41B of debt, a net debt position of $2.79B.
Jazz Pharmaceuticals does not currently pay a dividend.
The share price is up 59.7% over the past year. At $214.42 (the Oct 15, 2026 close) it sits within its 52-week range of $128.80 to $266.38, above its 200-day moving average of $214.05.
Based on 20 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $298.17, 39.1% above the Oct 15, 2026 close.
Frequently Asked Questions About Jazz Pharmaceuticals
What is the current stock price for JAZZ?
As of the Oct 15, 2026 close, JAZZ stock trades at $214.42. The 52-week range is $128.80–$266.38, with a day range of $212.19–$217.57.
What is the P/E ratio for JAZZ?
As of the Oct 15, 2026 close, Jazz Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 15.8, meaning investors pay $15.8 for every $1 of annual earnings. Jazz Pharmaceuticals operates in the Healthcare sector.
Does JAZZ pay dividends?
Jazz Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for JAZZ?
Based on ratings from 20 professional analysts over the last 90 days, the consensus for JAZZ is Buy. The average 12-month price target is $298.17, a 39.1% upside from the Oct 15, 2026 close of $214.42.
What is the market cap of JAZZ?
As of the Oct 15, 2026 close, Jazz Pharmaceuticals's market capitalization is $14.88B, classifying it as a large-cap company. Jazz Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.